GENB
Generate Biomedicines, Inc.
13.49
-0.29 (-2.10%)
52w low 11.00
22.67 high
21.3% of range
Financial Analysis
| (USD) | Dec 24 | Dec 25 | Trend |
|---|---|---|---|
| Cash & Equivalents | 176.27M | 121.65M | |
| Receivables | 308.00K | 0.00 | |
| Current Assets | 407.49M | 234.37M | |
| Net PP&E | 101.07M | 89.01M | |
| Total Assets | 518.26M | 330.18M | |
| Current Liabilities | 86.63M | 82.20M | |
| Total Debt | 76.97M | 68.53M | |
| Total Liabilities | 953.35M | 953.38M | |
| Retained Earnings | -473.14M | -676.29M | |
| Shareholders Equity | -434.52M | -615.97M | |
| Working Capital | 320.87M | 152.16M | |
| Shares Outstanding | 127.45M | 127.45M |
Revenue CAGR
+55.9%
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+55.9%